Company · CIK 0001819411 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Gain Therapeutics, Inc. · GANX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 17, 8:33 am EDT | Dov A Goldstein M.D.Director | 25,000 | — | — | 25,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 8:32 am EDT | Claude NicaiseDirector | 25,000 | — | — | 25,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 8:32 am EDT | Khalid IslamDirector | 25,000 | — | — | 25,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 8:31 am EDT | Gwen A MelincoffDirector | 25,000 | — | — | 25,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 8:31 am EDT | Jeffrey Scott RileyDirector | 25,000 | — | — | 25,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 8:30 am EDT | Hans Peter HaslerDirector | 25,000 | — | — | 25,000 | — |